These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 2424075)

  • 1. Platelet alpha-granule release in chronic myeloproliferative disorders with thrombocytosis.
    Sacchi S; Curci G; Piccinini L; Messerotti A; Cucci F; Bursi R; Zaniol P; Torelli U
    Scand J Clin Lab Invest; 1986 Apr; 46(2):163-6. PubMed ID: 2424075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet factor-4 excretion in myeloproliferative disease: implications for the aetiology of myelofibrosis.
    Burstein SA; Malpass TW; Yee E; Kadin M; Brigden M; Adamson JW; Harker LA
    Br J Haematol; 1984 Jul; 57(3):383-92. PubMed ID: 6743563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study of haemostatic parameters in relation to the clinical course of myeloproliferative disorders.
    Wehmeier A; Fricke S; Scharf RE; Schneider W
    Eur J Haematol; 1990 Oct; 45(4):191-7. PubMed ID: 2146144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-thromboglobulin (beta-TG) and platelet factor 4 (PF4) release by adenosine diphosphate (ADP) contact with native whole blood.
    Pengo V; Boschello M; Prandoni P; Schivazappa L; Girolami A
    Thromb Res; 1985 Sep; 39(5):645-50. PubMed ID: 2417360
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical significance of beta-thromboglobulin in patients with high platelet count.
    Fabris F; Randi ML; Casonato A; Dal Bo Zanon R; Bonvicini P; Girolami A
    Acta Haematol; 1984; 71(1):32-8. PubMed ID: 6197855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A formula for correcting for the in vitro release of platelet beta-thromboglobulin.
    van Wyk V; Heyns AD; de Wet JI; Kotzé HF; Lötter MG
    Thromb Res; 1987 Jun; 46(5):659-68. PubMed ID: 2957816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet and plasma beta thromboglobulin in myeloproliferative syndromes and secondary thrombocytosis.
    Boughton BJ; Allington MJ; King A
    Br J Haematol; 1978 Sep; 40(1):125-32. PubMed ID: 81681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal levels of platelet-specific proteins and mitogenic activity in myeloproliferative disease.
    Rueda F; Piñol G; Marti F; Pujol-Moix N
    Acta Haematol; 1991; 85(1):12-5. PubMed ID: 1826402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of enhanced in vivo platelet alpha-granule release in different patient groups--comparison of beta-thromboglobulin, platelet factor 4 and thrombospondin assays.
    Lane DA; Ireland H; Wolff S; Ranasinghe E; Dawes J
    Thromb Haemost; 1984 Oct; 52(2):183-7. PubMed ID: 6084323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet function and structure in myeloproliferative disease, myelodysplastic syndrome, and secondary thrombocytosis.
    Raman BK; Van Slyck EJ; Riddle J; Sawdyk MA; Abraham JP; Saeed SM
    Am J Clin Pathol; 1989 Jun; 91(6):647-55. PubMed ID: 2524965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-thromboglobulin content in megakaryocytes of patients with myeloproliferative diseases.
    Grossi A; Vannucchi AM; Rafanelli D; Filimberti E; Rossi Ferrini P
    Thromb Res; 1986 Aug; 43(3):367-74. PubMed ID: 2426823
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet activation in myeloproliferative disorders.
    Cortelazzo S; Viero P; Barbui T
    Thromb Haemost; 1981 Jun; 45(3):211-3. PubMed ID: 6169172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of beta TG/PF4 ratio in patients with high platelet count.
    Fabris F; Luzzatto G; Girolami A
    Thromb Haemost; 1985 Apr; 53(2):288-9. PubMed ID: 2410998
    [No Abstract]   [Full Text] [Related]  

  • 14. The release of beta-thromboglobulin and platelet factor 4 during extracorporeal circulation for open heart surgery.
    Cella G; Vittadello O; Gallucci V; Girolami A
    Eur J Clin Invest; 1981 Jun; 11(3):165-9. PubMed ID: 6168469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the beta TG/PF4 ratio have any value in myeloproliferative diseases?
    Viero P; Cortelazzo S; Barbui T
    Thromb Haemost; 1984 Jul; 51(3):411. PubMed ID: 6208631
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet alpha granule release in diabetes mellitus.
    Sacchi S; Curci G; Piccinini L; Cucci F; Messerotti A; Roncaia R; Benedetti PG
    Scand J Clin Lab Invest; 1985 Apr; 45(2):165-8. PubMed ID: 2408317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between low affinity platelet factor 4 (LA-PF4) and beta-thromboglobulin (beta TG).
    Niewiarowski S
    Thromb Haemost; 1980 Aug; 44(1):47. PubMed ID: 6158765
    [No Abstract]   [Full Text] [Related]  

  • 18. Utilization of the platelet release reaction in the blood compatibility assessment of polymers.
    Bowry SK; Courtney JM; Prentice CR; Douglas JT
    Biomaterials; 1984 Sep; 5(5):289-92. PubMed ID: 6207864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of beta-thromboglobulin, platelet factor 4, and fibrinopeptide A in erythrocytosis due to cyanotic congenital heart disease.
    Rosove MH; Hocking WG; Harwig SS; Perloff JK
    Thromb Res; 1983 Jan; 29(2):225-35. PubMed ID: 6189239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma and platelet beta-thromboglobulin levels in patients with May-Hegglin anomaly.
    Fabris F; Casonato A; Randi ML; Girolami A
    Haemostasis; 1980; 9(2):126-30. PubMed ID: 6153630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.